Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
about
Plasmacytoid dendritic cells: linking innate and adaptive immunityAdjuvants: Classification, Modus Operandi, and LicensingMechanisms of HIV protein degradation into epitopes: implications for vaccine designAssociation of TLR7 variants with AIDS-like disease and AIDS vaccine efficacy in rhesus macaquesToll-Like Receptors and Viruses: Induction of Innate Antiviral Immune ResponsesImiquimod: mode of actionA randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.Incorporation of CD40 ligand into the envelope of pseudotyped single-cycle Simian immunodeficiency viruses enhances immunogenicity.The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategiesThe present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?Activation of tonsil dendritic cells with immuno-adjuvants.Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection.Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha responseCross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cellsDynamics of dendritic cell maturation are identified through a novel filtering strategy applied to biological time-course microarray replicatesImpaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and production.Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands.Generation of T cell responses targeting the reactive metabolite of halothane in mice.Dendritic cell-based human immunodeficiency virus vaccine.Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells.Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DCSystemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells.Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses.HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates.Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling.Interleukin-12: an update on its immunological activities, signaling and regulation of gene expressionPlasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosisNew approaches to design HIV-1 T-cell vaccinesDecreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infectionPrevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliterationPD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.Resiquimod and other immune response modifiers as vaccine adjuvants.Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C)The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient miceIFN-α produced by human plasmacytoid dendritic cells enhances T cell-dependent naïve B cell differentiationPriming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infectionNKT cells and viral immunity.TLR9 -1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants
P2860
Q24558695-2F294139-6A66-463D-8946-3A1257826AF5Q26747586-D5024C80-BAB3-4992-9492-618453D605D9Q26866505-4C4CD7F4-F841-4477-96BB-981E58D0B094Q27318249-88A4C52A-2D7B-4FD1-BAE3-42B5B6C673BDQ27487393-8A9E9BA8-96C4-40E8-8B2C-90FFDC67AAD6Q28260444-E55F0117-A5DD-4D10-A48A-DC351255D734Q30278070-F01AB5DD-AE84-4925-AA13-C0AA58812555Q30350301-9AF78A31-FA75-43E0-A45A-E5B57B99597FQ30373512-93060C97-F886-40F0-BC93-C29CD9DD094CQ30374404-B93847DE-E191-4742-8FFE-21A997198468Q30425111-21A03710-6332-409F-A9B0-CFB756CF70E3Q33325670-C92506F7-C10B-4199-AC3F-00382102C9BEQ33397372-27F2B378-A976-427A-AF9C-EAC5F6572CE8Q33598425-5BCD114E-2FFC-4697-8C2E-2D6EDDEE7DDEQ33613138-FA82D5A6-61D8-4E6B-B4B3-96C5C776E12DQ33648536-0AF49865-EFF7-4020-972B-EC5FD49F5CA8Q33707350-3ABD81B8-F78F-4AFC-9802-D6C088C358B9Q33725882-B8A2A399-A908-4CF7-8A73-89C38F5741E4Q33835976-9FA93BD8-6076-4715-B985-AE6DEF4A0F49Q33874652-78739661-E274-47A4-A6E3-7CB82E64683AQ33884007-7C5BD1D0-9610-4FAD-BDBC-C55BAC948D52Q33940675-69C16008-530F-42FD-B8A3-C57D5A81F1CCQ34017771-9C33363A-EBB7-4F0E-8244-DF8CB4D99E5DQ34025136-C16DEF84-9EA7-4993-A480-2005D9A64CF1Q34085119-960BB901-5C74-4F2E-B641-0453035C2DCAQ34229687-B7CDE5DF-EA26-4FDC-A47D-7E90E804A7A2Q34248780-5918B8CE-3070-4EB0-A781-505640039322Q34261832-CBA12F0A-2282-49DC-BECB-A29AE2A5CD83Q34274849-A6DCDE98-DD79-448B-A4D6-616DBB4BCC85Q34282702-30B4F7E2-B826-44B7-99CD-4F91B20A9D43Q34372089-1DFB4003-FC98-4510-8FEB-47A714523D75Q34570624-11671803-B92D-4CB3-952C-9D715EA3ED11Q34700325-29F8670B-8EA3-47DC-AC80-C027889DE936Q34732473-9795F2FF-4301-4A2D-BDC0-28A32EE52070Q34774050-BAB2821E-F86B-4A2C-8C7E-F6DE53CCB1F8Q35001944-B1A1BE94-2735-42C3-B0C1-FC9A63C7291CQ35067616-3CEA77FA-9E21-4F09-BA68-B446948B1DABQ35531527-F8092400-055F-4BF8-B2A3-47AF5B5836AAQ35798179-40FE2A48-9EFA-4FFA-A494-5D9FAE1D65E4Q35996996-8B450EAA-2511-426F-96E8-E7A53E54D62B
P2860
Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Toll-like receptor ligands mod ...... V-1-specific T cell responses.
@en
type
label
Toll-like receptor ligands mod ...... V-1-specific T cell responses.
@en
prefLabel
Toll-like receptor ligands mod ...... V-1-specific T cell responses.
@en
P2093
P1476
Toll-like receptor ligands mod ...... V-1-specific T cell responses.
@en
P2093
Janaki Kuruppu
Jason M Brenchley
Karin Loré
Mario Roederer
Michael R Betts
Richard A Koup
Robert A Seder
Soorena Khojasteh
Stephen Perfetto
P304
P356
10.4049/JIMMUNOL.171.8.4320
P407
P577
2003-10-01T00:00:00Z